Literature DB >> 2786504

Antigenic evidence for simultaneous expression of two different lipooligosaccharides by some strains of Haemophilus influenzae type b.

C C Patrick1, S E Pelzel, E E Miller, E Haanes-Fritz, J D Radolf, P A Gulig, G H McCracken, E J Hansen.   

Abstract

Isolates of Haemophilus influenzae type b (Hib) can be divided into three antigenic groups based on their reactivities with a set of two monoclonal antibodies (MAbs) directed against epitopes in the oligosaccharide region of Hib lipooligosaccharide (LOS) (P. A. Gulig, C. C. Patrick, L. Hermanstorfer, G. H. McCracken, Jr., and E. J. Hansen, Infect. Immun. 55:513-520, 1987). Approximately 24% of Hib strains react with both of these LOS-specific MAbs. Immunoprecipitation experiments involving several of these strains indicated that the epitopes recognized by these MAbs resided in two different LOS molecules, both of which were synthesized by these particular Hib strains. In addition, Western blot (immunoblot) analysis of proteinase K-treated cell extracts of these strains that had been subjected to sodium dodecyl sulfate-polyacrylamide gradient gel electrophoresis revealed two different LOS staining patterns when they were probed independently with the two MAbs. Colony blot radioimmunoassay of hundreds of colonies of one of these Hib strains showed that each colony bound both MAbs. Immune electron microscopy confirmed that individual cells of this same Hib strain expressed both types of LOS molecule at the same time. An antibody accessibility radioimmunoassay was used to show that different Hib strains of this type varied in the relative amounts of each of the two MAbs that they could bind to their cell surfaces. These findings indicate that some Hib strains can synthesize two antigenically distinct LOS molecules simultaneously.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786504      PMCID: PMC313829          DOI: 10.1128/iai.57.7.1971-1978.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

2.  A minor high-molecular-weight outer membrane protein of Haemophilus influenzae type b is a protective antigen.

Authors:  A Kimura; P A Gulig; G H McCracken; T A Loftus; E J Hansen
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

3.  Immunochemical studies on the lipopolysaccharides of Bordetella pertussis.

Authors:  M A Aprile; A C Wardlaw
Journal:  Can J Microbiol       Date:  1973-02       Impact factor: 2.419

4.  Ultrastructural localization of specific gonococcal macromolecules with antibody-gold sphere immunological probes.

Authors:  E N Robinson; Z A McGee; J Kaplan; M E Hammond; J K Larson; T M Buchanan; G K Schoolnik
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

5.  Physical heterogeneity of neisserial lipooligosaccharides reflects oligosaccharides that differ in apparent molecular weight, chemical composition, and antigenic expression.

Authors:  J M Griffiss; J P O'Brien; R Yamasaki; G D Williams; P A Rice; H Schneider
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

6.  The lipopolysaccharides of Neisseria gonorrhoeae colony types 1 and 4.

Authors:  M B Perry; V Daoust
Journal:  Can J Biochem       Date:  1975-05

7.  Differential complement resistance mediates virulence of Haemophilus influenzae type b.

Authors:  A Sutton; R Schneerson; S Kendall-Morris; J B Robbins
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

Review 8.  Vaccine prevention of Haemophilus influenzae type b disease: past, present and future.

Authors:  S L Cochi; C V Broome
Journal:  Pediatr Infect Dis       Date:  1986 Jan-Feb

9.  Haemophilus influenzae type b lipooligosaccharide: stability of expression and association with virulence.

Authors:  A Kimura; C C Patrick; E E Miller; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

10.  Prospects for prevention of Haemophilus influenzae type b disease by immunization.

Authors:  D M Granoff; R S Munson
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

View more
  10 in total

1.  The LspB protein is involved in the secretion of the LspA1 and LspA2 proteins by Haemophilus ducreyi.

Authors:  Christine K Ward; Jason R Mock; Eric J Hansen
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

2.  Identification of a new locus involved in expression of Haemophilus influenzae type b lipooligosaccharide.

Authors:  G P Jarosik; E J Hansen
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

3.  Identification of tandem genes involved in lipooligosaccharide expression by Haemophilus ducreyi.

Authors:  M K Stevens; J Klesney-Tait; S Lumbley; K A Walters; A M Joffe; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

4.  Lack of expression of the global regulator OxyR in Haemophilus influenzae has a profound effect on growth phenotype.

Authors:  I Maciver; E J Hansen
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  A system for generalized mutagenesis of Haemophilus ducreyi.

Authors:  M K Stevens; L D Cope; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

6.  Cloning and expression in Escherichia coli of a Haemophilus influenzae type b lipooligosaccharide synthesis gene(s) that encodes a 2-keto-3-deoxyoctulosonic acid epitope.

Authors:  S M Spinola; Y A Kwaik; A J Lesse; A A Campagnari; M A Apicella
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

7.  Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b.

Authors:  L D Cope; R Yogev; J Mertsola; J C Argyle; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

8.  Nontypeable Haemophilus influenzae: pathogenesis and prevention.

Authors:  A R Foxwell; J M Kyd; A W Cripps
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

9.  Identification of gene products involved in biofilm production by Moraxella catarrhalis ETSU-9 in vitro.

Authors:  Melanie M Pearson; Eric J Hansen
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

10.  Haemophilus ducreyi secretes a filamentous hemagglutinin-like protein.

Authors:  C K Ward; S R Lumbley; J L Latimer; L D Cope; E J Hansen
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.